Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1Phase 1 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3NIH 1FED 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 2Head & Neck 1CNS 1

Conditions

Breast Neoplasms 852Neoplasms 643Prostatic Neoplasms 439Lung Neoplasms 359Colorectal Neoplasms 327Carcinoma, Non-Small-Cell Lung 318Leukemia, Myeloid, Acute 251Pancreatic Neoplasms 218Brain Neoplasms 202Multiple Myeloma 198Neoplasm Metastasis 191Carcinoma, Hepatocellular 178Head and Neck Neoplasms 176Glioblastoma 167Precursor Cell Lymphoblastic Leukemia-Lymphoma 166Melanoma 153Ovarian Neoplasms 149Squamous Cell Carcinoma of Head and Neck 148Rectal Neoplasms 134Recurrence 132Hematologic Neoplasms 125Sarcoma 124Uterine Cervical Neoplasms 117Stomach Neoplasms 116Carcinoma, Renal Cell 115Triple Negative Breast Neoplasms 114Glioma 114Motor Activity 100Myelodysplastic Syndromes 96Esophageal Neoplasms 96

Interventions

sodium thiosulfate 1Platinum 1Magnetic Resonance Spectroscopy 1Hearing Tests 1Hearing 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Hearing Loss × 90 days × Clear all
NCT07407582 2026-06-05

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

University of Arizona

Phase 1/2 Recruiting
25 enrolled
GenitourinaryHead & Neck

Head and Neck Neoplasms, Neoplasms, Testicular Neoplasms, Hearing Loss

NCT06781749 2026-05-11

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

University of Southern California

Recruiting
100 enrolled

Dementia, Hearing Loss

NCT07420751 2026-04-28

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Massachusetts General Hospital

Phase NA Active not recruiting
18 enrolled
CNS

Neurofibromatosis 2, Hearing Loss

NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed
476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡